TNXP
TNXP
NASDAQ · Biotechnology

Tonix Pharmaceuticals Holdin

$3.01
-0.23 (-7.10%)
As of Nov 15, 10:38 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,253.5% upside
Low Target $28.14
Average Target $40.74
High Target $50.62
Current Price $3.01
Current
$3.01
Target
$40.74
$28.14 $40.74 avg $50.62
Scenario Analysis
Bear Case
$28.14
834.9%
Low target
Base Case
$40.74
+1,253.5%
Avg target
Bull Case
$50.62
+1,581.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$20.56
-85.4% from high
52-Week Low
$3.21
+-6.2% from low
Target vs 52W High
$40.74
+98.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%